MentalHealthDaily

Repetitive TMS for Alzheimer’s Disease Alters Brain Waves & Enhances Cognition (2024 Study)

Repetitive transcranial magnetic stimulation (rTMS) is making waves in the field of Alzheimer’s disease (AD) research, offering a glimmer of hope for enhancing cognitive functions in patients. By targeting specific brain regions, rTMS has shown promising results in modulating neural activity and improving cognitive scores. This innovative therapy, coupled with real-time monitoring through electroencephalography (EEG), …

Berberine for Alzheimer’s Disease Treatment: Mechanisms & Efficacy (2023 Review)

by GLOOM

In the quest for more effective treatments for Alzheimer’s Disease (AD), berberine, a bioactive compound derived from traditional Chinese medicine, has emerged as a promising candidate. Recent preclinical studies have showcased its potential to combat the debilitating effects of AD, with evidence pointing towards its ability to improve cognitive functions, reduce hallmark AD pathologies such …

Ultra-Processed Foods (UPF) Linked to Increased Alzheimer’s Disease Risk (2023 Review)

by GLOOM

In the modern dietary landscape, ultra-processed foods (UPFs) have become a staple in many diets, celebrated for their convenience and palatability. However, emerging research reveals a concerning association between UPF consumption and increased risk of Alzheimer’s disease (AD), a leading cause of dementia. Highlights: Strong Link: Recent systematic reviews indicate a strong link between high …

Caffeine to Prevent Alzheimer’s Disease via Adenosine A2A Receptors? (2023 Review)

by GLOOM

Alzheimer’s Disease (AD), a prevalent form of dementia, poses significant challenges for individuals and healthcare systems worldwide. Current treatments primarily offer symptomatic relief without altering the disease’s progression. However, emerging research suggests that caffeine, a widely consumed psychoactive substance, may have neuroprotective properties against AD. Highlights: Alzheimer’s Disease is the most common form of dementia, …

Olibanum Gum Ineffective for Mild-to-Moderate Alzheimers Disease (2023 Study)

by GLOOM

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline, significantly impacting the elderly. A recent clinical trial investigated the memory-improving potential of Olibanum, a traditional herbal remedy, in AD patients. Highlights: Alzheimer’s disease is a leading cause of dementia, characterized by memory loss and cognitive impairment. Olibanum, also known as Frankincense, has a …

Insulin & Blood Sugar vs. Cognitive Function & Psychiatric Disorders (2023 Evidence)

by GLOOM

Hyperglycemia, or high blood sugar, is more than a mere symptom of diabetes; it’s a complex condition that may significantly impact cognitive functions like memory and attention. While the association between diabetes and physical health complications is well known, there’s a growing body of research exploring how altered insulin signaling, a key feature of diabetes, …

Alzheimer’s Disease, Microglia, & Environmental Risk Factors (2024 Evidence)

by GLOOM

Alzheimer’s disease, a debilitating neurodegenerative condition, is influenced significantly by a blend of genetic, environmental, and lifestyle factors. New research focuses on environmental risk factors and microglia (the brain’s immune cells) for Alzheimer’s development. Highlights: Alzheimer’s Disease and Microglia: Alzheimer’s is characterized by cognitive decline, and microglia play a crucial role in its pathogenesis, acting …